Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting
December 07, 2024 12:00 ET | Source: Y-mAbs Therapeutics, Inc. NEW YORK,…
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Associations 35th International Symposium on ALS/MND
BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ:…
MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
December 05, 2024 18:00 ET | Source: MediciNova, Inc. LA JOLLA, Calif.,…
OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World
This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy…
OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World
This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy…
OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World
This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy…
OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World
This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy…
OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World
This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy…
OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World
This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy…
Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients…